For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Vor Biopharma Inc.

USPTO Granted Patents = 12

Trademarks = 3

Forward Citations = 26

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

Aleksandar Filip Radovic-Moreno (9 out of 22 patents)

John Lydeard (9 out of 9 patents)

Joseph Beene Bolen (9 out of 18 patents)

4. Anthony Boitano (3 out of 14 patents)

5. Michael Cooke (3 out of 6 patents)

6. Bradley R Pearse (2 out of 6 patents)

7. Rahul Palchaudhuri (2 out of 9 patents)

8. Paul Fredrick Widboom (1 out of 2 patents)

9. Sean McDonough (1 out of 6 patents)

10. Rajiv Panwar (1 out of 5 patents)

11. Patricia Ann Cruite (1 out of 2 patents)

12. Geoffrey O Gillard (1 out of 1 patent)

13. Jennifer Lynn Proctor (1 out of 1 patent)

14. Charlotte Fenton McDonagh (1 out of 1 patent)

15. Hillary Adams (1 out of 1 patent)

12 patents: Sort by Forward Citations

1. 12403200 - Methods and compositions for treating autoimmune diseases (2025-09-02),

2. 12291576 - Anti-CD45 antibodies and conjugates thereof (2025-05-06),

3. 12251403 - Genetically engineered hematopoietic stem cells and uses thereof (2025-03-18),

4. 12209135 - Anti-CD45 antibodies and conjugates thereof (2025-01-28),

5. 11975029 - Compositions and methods for inhibition of lineage specific proteins (2024-05-07),

6. 11903973 - Genetically engineered hematopoietic stem cells and uses thereof (2024-02-20),

7. 11571445 - Genetically engineered hematopoietic stem cells and uses thereof (2023-02-07),

8. 11559551 - Genetically engineered hematopoietic stem cells and uses thereof (2023-01-24),

9. 11464807 - Genetically engineered hematopoietic stem cells and uses thereof (2022-10-11),

10. 11389485 - Genetically engineered hematopoietic stem cells and uses thereof (2022-07-19),

11. 11382932 - Genetically engineered hematopoietic stem cells and uses thereof (2022-07-12),

12. 10925902 - Genetically engineered hematopoietic stem cells and uses thereof (2021-02-23),

Vor Biopharma Inc. is a clinical-stage cell therapy company focused on developing novel treatment for hematologic malignancies. Leveraging their innovative technology platform, Vor Biopharma is dedicated to delivering potentially curative therapies to patients in need.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

12 Patents

#177 in Cambridge, MA

#1,503 in Massachusetts

#24,831 in US

#46,738 in the World

Cambridge, MA, United States of America

Vor Biopharma Inc.

Forward Citations = 26

15 inventors:

Aleksandar Filip Radovic-Moreno (9 out of 22 patents)

John Lydeard (9 out of 9 patents)

Joseph Beene Bolen (9 out of 18 patents)

4. Anthony Boitano (3 out of 14 patents)

5. Michael Cooke (3 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…